News & Articles

Harnessing the most powerful force in the fight against disease — natural human immunity

The first 4,000 doses have been delivered for use in the Phase 2/3 clinical trial COV002 by the University of Oxford

First patients are expected to be enrolled shortly and additional European regulatory approvals are in process

People who recovered from COVID-19 shows that most individuals had generated antibodies that were intrinsically capable of neutralizing the SARS-CoV-2 virus

Cambridge Cognition has secured over $1.5 million in new contracts to support pharmaceutical clients in delivering virtual clinical trials

The cPass™ – SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit aims to detect the presence of neutralizing antibodies in an hour

Download this white paper from Sartorius to discover how enhanced data analytics and translational models can provide new biological insights

The company aims to ramp up its production capacity of more than 50 million antibody tests per month

Test will be available at NHS laboratories across the UK, using its ARCHITECT i1000SR and i2000SR and Alinity i laboratory instruments

Interim clinical study data shows ID NOW test performance of 94.7% sensitivity and 98.6% specificity

Driven by the gap in COVID-19 testing, the collaboration aims to create a fully disposable, rapid and handheld test for consumers

A qualitative test for the detection of nucleic acid from SARS-CoV-2

Study suggests that type I IFN deficiency in the blood could help define a high-risk population

The COVID-19 vaccine trial is part of a global development program that will uncover the safety and immunogenicity of four mRNA vaccine candidates.

Test deployed on Quanterix' Simoa platform promises 1,000-fold sensitivity improvement

Science industry comes together online to share knowledge and provide technology solutions for cancer and immunology research

Assay will help guide treatment decisions in cases of non-small cell lung cancer

The company says it continues to optimize its coronavirus test amid questions about its accuracy

Collaboration with WuXi Diagnostics and Mayo Clinic on serology test will complement Thermo Fisher's widely adopted TaqPath COVID-19 molecular diagnostic test